Filtered By:
Source: Acta Bio-Medica : Atenei Parmensis
Management: WHO

This page shows you your search results in order of date.

Order by Relevance | Date

Total 112 results found since Jan 2013.

COVID-19: opinions and behavior of Italian general population during the first epidemic phase
CONCLUSION: The results of the present study could help public health authorities in carrying out informative campaigns for general population and could be an important tool in evaluating public knowledge and misperceptions during the management of the COVID-19. (www.actabiomedica.it).PMID:35775780 | DOI:10.23750/abm.v93i3.12262
Source: Acta Bio-Medica : Atenei Parmensis - July 1, 2022 Category: General Medicine Authors: Cristina Genovese Vincenza La Fauci Angela Di Pietro Giuseppe Trimarchi Anna Odone Alessandra Casuccio Claudio Costantino Vincenzo Restivo Mariapia Fantini Davide Gori Antonio Azara Giovanna Deiana Silvana Castaldi Elena Righi Lucia Palandri Giovanni Panc Source Type: research

An overview of possible solutions putting an end to the COVID-19 pandemic
Acta Biomed. 2022 May 11;93(2):e2022202. doi: 10.23750/abm.v93i2.12130.ABSTRACTIn early 2020, a novel coronavirus, SARS-CoV2, started to spread throughout the world. The World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) as a pandemic on March 5, 2020. This 2020's pandemic has to date caused about 200,000 deaths and is still affecting the lives of people worldwide. No solitary solution can overcome the multidimensional challenges associated with the problem of COVID-19. Here, we provide a rapid overview of possible solutions offered by the epidemiological, pharmacological, immunological, and a...
Source: Acta Bio-Medica : Atenei Parmensis - May 12, 2022 Category: General Medicine Authors: Saina Adiban Afkham Amirhossein Hessami Amene Saghazadeh Nima Rezaei Source Type: research

SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait!
Acta Biomed. 2022 May 11;93(2):e2022097. doi: 10.23750/abm.v93i2.12712.ABSTRACTOn November 26th, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), B.1.1.529, was designated by the World Health Organization (WHO), named Omicron, and classified as a variant of concern (VOC). The news raised an international alarm about a new wave of coronavirus disease 2019 (Covid-19) outbreak, since Omicron has a large group of mutations which may affect the way it spread, cause disease, and escape from the immunity. Therefore, it is essential to take a closer look at how it has emerged, how it may sustain the pandemic, an...
Source: Acta Bio-Medica : Atenei Parmensis - May 12, 2022 Category: General Medicine Authors: Shayan Rahmani Nima Rezaei Source Type: research

An overview of possible solutions putting an end to the COVID-19 pandemic
Acta Biomed. 2022 May 11;93(2):e2022202. doi: 10.23750/abm.v93i2.12130.ABSTRACTIn early 2020, a novel coronavirus, SARS-CoV2, started to spread throughout the world. The World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) as a pandemic on March 5, 2020. This 2020's pandemic has to date caused about 200,000 deaths and is still affecting the lives of people worldwide. No solitary solution can overcome the multidimensional challenges associated with the problem of COVID-19. Here, we provide a rapid overview of possible solutions offered by the epidemiological, pharmacological, immunological, and a...
Source: Acta Bio-Medica : Atenei Parmensis - May 12, 2022 Category: General Medicine Authors: Saina Adiban Afkham Amirhossein Hessami Amene Saghazadeh Nima Rezaei Source Type: research

SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait!
Acta Biomed. 2022 May 11;93(2):e2022097. doi: 10.23750/abm.v93i2.12712.ABSTRACTOn November 26th, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), B.1.1.529, was designated by the World Health Organization (WHO), named Omicron, and classified as a variant of concern (VOC). The news raised an international alarm about a new wave of coronavirus disease 2019 (Covid-19) outbreak, since Omicron has a large group of mutations which may affect the way it spread, cause disease, and escape from the immunity. Therefore, it is essential to take a closer look at how it has emerged, how it may sustain the pandemic, an...
Source: Acta Bio-Medica : Atenei Parmensis - May 12, 2022 Category: General Medicine Authors: Shayan Rahmani Nima Rezaei Source Type: research

An overview of possible solutions putting an end to the COVID-19 pandemic
Acta Biomed. 2022 May 11;93(2):e2022202. doi: 10.23750/abm.v93i2.12130.ABSTRACTIn early 2020, a novel coronavirus, SARS-CoV2, started to spread throughout the world. The World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) as a pandemic on March 5, 2020. This 2020's pandemic has to date caused about 200,000 deaths and is still affecting the lives of people worldwide. No solitary solution can overcome the multidimensional challenges associated with the problem of COVID-19. Here, we provide a rapid overview of possible solutions offered by the epidemiological, pharmacological, immunological, and a...
Source: Acta Bio-Medica : Atenei Parmensis - May 12, 2022 Category: General Medicine Authors: Saina Adiban Afkham Amirhossein Hessami Amene Saghazadeh Nima Rezaei Source Type: research

SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait!
Acta Biomed. 2022 May 11;93(2):e2022097. doi: 10.23750/abm.v93i2.12712.ABSTRACTOn November 26th, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), B.1.1.529, was designated by the World Health Organization (WHO), named Omicron, and classified as a variant of concern (VOC). The news raised an international alarm about a new wave of coronavirus disease 2019 (Covid-19) outbreak, since Omicron has a large group of mutations which may affect the way it spread, cause disease, and escape from the immunity. Therefore, it is essential to take a closer look at how it has emerged, how it may sustain the pandemic, an...
Source: Acta Bio-Medica : Atenei Parmensis - May 12, 2022 Category: General Medicine Authors: Shayan Rahmani Nima Rezaei Source Type: research

An overview of possible solutions putting an end to the COVID-19 pandemic
Acta Biomed. 2022 May 11;93(2):e2022202. doi: 10.23750/abm.v93i2.12130.ABSTRACTIn early 2020, a novel coronavirus, SARS-CoV2, started to spread throughout the world. The World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) as a pandemic on March 5, 2020. This 2020's pandemic has to date caused about 200,000 deaths and is still affecting the lives of people worldwide. No solitary solution can overcome the multidimensional challenges associated with the problem of COVID-19. Here, we provide a rapid overview of possible solutions offered by the epidemiological, pharmacological, immunological, and a...
Source: Acta Bio-Medica : Atenei Parmensis - May 12, 2022 Category: General Medicine Authors: Saina Adiban Afkham Amirhossein Hessami Amene Saghazadeh Nima Rezaei Source Type: research

SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait!
Acta Biomed. 2022 May 11;93(2):e2022097. doi: 10.23750/abm.v93i2.12712.ABSTRACTOn November 26th, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), B.1.1.529, was designated by the World Health Organization (WHO), named Omicron, and classified as a variant of concern (VOC). The news raised an international alarm about a new wave of coronavirus disease 2019 (Covid-19) outbreak, since Omicron has a large group of mutations which may affect the way it spread, cause disease, and escape from the immunity. Therefore, it is essential to take a closer look at how it has emerged, how it may sustain the pandemic, an...
Source: Acta Bio-Medica : Atenei Parmensis - May 12, 2022 Category: General Medicine Authors: Shayan Rahmani Nima Rezaei Source Type: research